TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Syngene International Ltd. ( (IN:SYNGENE) ) has shared an announcement.
Syngene International Ltd. announced a significant change in its senior management with the departure of Mr. Alex Del Priore, Head of Large Molecules CDMO, and the appointment of Dr. Rohtash Kumar as the new Head of CDMO for both small and large molecules. This transition is expected to strengthen Syngene’s capabilities in pharmaceutical operations, leveraging Dr. Kumar’s extensive experience in R&D and manufacturing, which could enhance the company’s competitive positioning in the global CDMO market.
More about Syngene International Ltd.
Syngene International Ltd. operates in the biotechnology industry, focusing on contract research, development, and manufacturing services. It specializes in providing solutions for small and large molecule development, catering to pharmaceutical and biotechnology companies globally.
Average Trading Volume: 64,564
Technical Sentiment Signal: Hold
Current Market Cap: 263.6B INR
See more insights into SYNGENE stock on TipRanks’ Stock Analysis page.